# Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs

> **NCT07136701** · — · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 600 (estimated)

## Conditions studied

- Pancreatic Neuroendocine Neoplasms (pNETs)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07136701
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-31
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-07-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07136701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07136701, "Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07136701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*